ReviewClinical kidney journal2026
Ten tips for the diagnosis and management of fibromuscular dysplasia.
Review in Clinical kidney journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fibromuscular dysplasia (FMD) is an under-recognized, non-atherosclerotic, and non-inflammatory arteriopathy that predominantly affects women and can involve multiple vascular territories. It commonly presents with hypertension, cerebrovascular events, or arterial dissections in otherwise low-risk individuals, yet diagnostic delays and management variability remain frequent. This ten tips review provides practical guidance for clinicians to improve recognition, diagnosis, and management of FMD in everyday practice. Key recommendations emphasize maintaining a high index of suspicion in patients with early-onset or resistant hypertension, pre-eclampsia, pulsatile tinnitus, or unexplained headaches. High-quality imaging with computed tomographic angiography or magnetic resonance angiography is central to diagnosis, alongside a one-time head-to-pelvis vascular assessment to detect multivessel involvement. The review highlights the importance of recognizing atypical presentations-usually unexplained vascular events-and the limited role of routine genetic screening, while advocating selective evaluation of at-risk relatives. Management strategies, including percutaneous transluminal angioplasty, focus on individualized care. Medical management prioritizes strict blood pressure control, smoking cessation, and selective use of antiplatelet therapy, while statins are not routinely indicated. Lifestyle guidance supports regular physical activity with avoidance of high-risk activities that may predispose to dissection. Special considerations include pregnancy, which is generally safe with appropriate monitoring, and migraine management, which requires balancing efficacy with vascular safety. Finally, this review underscores the importance of multidisciplinary care, patient education, and participation in registries and support networks to advance knowledge and improve outcomes in this rare disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.